期刊文献+

血管紧张素Ⅱ对血管平滑肌细胞钙化的影响及信号通路 被引量:1

Effects of Angiotensin Ⅱ on the Calcification in Vascular Smooth Muscle Cells and Its Signal Pathway
下载PDF
导出
摘要 目的在钙化大鼠主动脉血管平滑肌细胞上观察血管紧张素Ⅱ对钙化的影响及其信号通道。方法用β磷酸甘油制备钙化的大鼠血管平滑肌细胞,再以血管紧张素Ⅱ,血管紧张素Ⅱ1型受体阻断剂缬沙坦,选择性蛋白激酶A或蛋白激酶C抑制剂等干预,通过Von Kossa染色及检测钙含量、碱性磷酸酶活性、骨钙素浓度和核心结合因子a1 mRNA表达来探讨血管紧张素Ⅱ对钙化的影响及其信号通道。结果血管紧张素Ⅱ增加钙化大鼠血管平滑肌细胞的钙含量、碱性磷酸酶活性、骨钙素浓度和核心结合因子a1 mRNA表达(P<0.05);而血管紧张素Ⅱ1型受体阻断剂和选择性蛋白激酶C抑制剂可阻断血管紧张素Ⅱ对血管平滑肌细胞的钙含量、碱性磷酸酶活性、骨钙素浓度和核心结合因子a1 mRNA表达的影响(P<0.05)。结论血管紧张素Ⅱ可促进β磷酸甘油诱导的血管平滑肌细胞钙化,其途径是通过血管紧张素Ⅱ1型受体,胞内信号途径是蛋白激酶C核心结合因子a1途径。 Aim To clarify the effects of angiotensin Ⅱ on the calcification in rat vascular smooth muscle cells ( VSMCs ) and its signal transduction. Methods Calcification of cultured rat VSMCs was prepared by incubation with β-glycerophosphate. Calcification was confirmed by Von Kossa staining, and calcium content, alkaline phosphatases activity, osteocalcin and core binding factor alpha 1 ( Cbfal ) mRNA expression were measured. Results Angiotensin Ⅱ enhanced the increase of calcium content, alkaline phosphatases activity, osteocalcin concentration and Cbfal mRNA expression in calcified VSMCs ( P 〈 0.05). Angiotensin Ⅱ type 1 receptor blocker valsartan and selective protein kinase C (PKC) inhibitor inhibited the effects of angiotensin Ⅱ on vascular calcification( P 〈 0.05). Condusions These data suggested that β-glycerophosphate-induced calcification in VSMCs was enhanced by angiotensin Ⅱ through angiotensin Ⅱ type 1 receptor and PKC-Cbfal pathway.
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第8期609-612,共4页 Chinese Journal of Arteriosclerosis
关键词 内科学 心血管 血管紧张素Ⅱ 大鼠 血管平滑肌细胞 钙化 信号通道 Cardiovascular Angiotensin Ⅱ Rat Vascular Smooth Muscle Cell Calcification Signal Pathway
  • 相关文献

参考文献10

  • 1Shioi A, Nishizawa Y,Jono S,Koyama H,Hosoi M,Mor ⅡH.Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells[J].Arterioscler thromb Vasc Biol,1995,15:2 003-009.
  • 2吴胜英,张宝红,蒋宏峰,潘春水,庞永政,唐朝枢,齐永芬.血管钙化对血管组织内皮素表达的影响[J].中国动脉硬化杂志,2003,11(4):277-282. 被引量:13
  • 3Dao HH, Essalihi R, Graillon .JF, Lariviere R, De-Champlain J, Moreau P. Pharmcological prevention and regression, of aiterlal remodeling in a rat model of isohted systolic hypertension [ J]. J Hypertens, 2002,20(8):1 597-606.
  • 4吴胜英,潘春水,刘秀华,蒋维,齐永芬,唐朝枢,李菊香.内源性血管紧张素Ⅱ对大鼠血管钙化的作用[J].中国病理生理杂志,2004,20(11):1961-1965. 被引量:14
  • 5Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated durng neointima formation in rat arteries and is a novelel component of human atherosclerotic plaques [J], J Clin Invest, 1993, 92 (4) : 1 686-696.
  • 6Wada T, McKee MD, Steitz S, Giachelli CM. Calcification of vascular smooth muscle cell cultures-Inhlbltion by osteopotin [J]. Circ Res, 1999, 84 (2): 166-178.
  • 7Zhang J, Fu M, Myles D, Zhu X, Du J, Cao X, et al. PDGF induces osteo protegerin expression in vascular smooth muscle cells by multiple signal pathways[J]. FEBS Lett 2002, 521 (1-3): 180-184.
  • 8XiaoG, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, etal. MAPK pathways activate and phosphorylate the osteoblast-spacific transcription factor, Cbfal [J]. J Biol Chem, 2000, 275 (6): 4 453-459.
  • 9Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD,Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the parados of arterial calcification in osteoporotic patients[J]. Arteriascler Vasc Biol, 1997, 17 (4) : 680-687.
  • 10Hiruma Y, Inoue A, Shiohama A, Otsuka E, Hirose S, Yamaguchi A, etal. Endothelins inhibit mineralization of rat calvarial osteoblast-like cells[J]. Pharmacol, 1998, 31 (Suppl 1) : S521-S523.

二级参考文献26

  • 1Mody N,Tintut Y, Badcliff K,Demer LL.Vascular calcification and its relation to bone calcification: Poesible undedying mechanisms. J Nucl Candiol,2003, 10 (2): 177-183.
  • 2Bostrom K.Insights into the mechanism of vascular calcification.Am J Cardiol,2001,88(2A):20E-22E
  • 3Wallin R.Arterial calcification:A review of mechanisms,animal models,and the prospects for therapy.Med Res Rev,2001,21(4):274-301
  • 4Iribararen C, Sidney S,Stemfeld B,Browner WS.Calcification of the aortic arch: risk factors and association with curonary heart disease,stroke,and peripheral vascular disease. JAMA, 2000, 283 (10) : 2810-815.
  • 5Proudfoot D,Skeppe JN,Catherine M.Calcification of human vascular cells in vitro is correlated with hight levels of matrix Gla Protein and low levels of osteoppontin expression.Aterioscler Thromb Vasc Biol,1998,18(3):379-388
  • 6Niederhoffer N,Bobryshey YV,Lartaud-Idjouadiene I,Giummelly P,Atkinson J.Aortic calcification produced by vitamin D3 plus nicotine.J Vasc Res,1997,34(5):386-398
  • 7Qi YF.Wang SH,Zhang BH,Bu DF,Shu TC,Du JB.Changes in amount of ADM mRNA and RAMP2 mRNA in calcified vascular smooth muscle cells.Peptides,2003,24(2):287-294
  • 8Shioi A,Nishizawa Y,Jono S.β-Glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells.Arteroscler Thromb Vasc Biol,1995,15(11):2003-009
  • 9Zhang B,Tang C,Jiang Z,Effects of adrenomedullin on vascular calcification in rats.Z Kardiol,2000,91(7):568-574
  • 10Lanske B,Amling M,Neff L,Guiducci J,Baron R,Kronenberg HM.Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct ahnormalities in bone development.J Clin Invest,1999,104(4):399-407

共引文献23

同被引文献40

  • 1潘振伟,吕延杰,初文峰,许超千,白云龙,单宏丽,杨宝峰.缺血性心律失常相关微小RNA在大鼠心脏的表达变化[J].哈尔滨医科大学学报,2007,41(2):95-97. 被引量:7
  • 2Yang B, Lin H, Xiao J, et al. The muscle-specific micmRNA miR-I regulates cardiac arrhythmogenic potential by targeting GJAI and KCNJ2 [J]. Nat Med, 2007, 13 (4) : 486-491.
  • 3Xiao J, Yang B, Lin H, et al. Novel approaches for gene-speeifie interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4 [ J ]. Cell Physiol, 2007, 212 (2) : 285-292.
  • 4Luo X, Lin H, Pan Z, et al. Dowuregulation of miRNA-1/miRNA-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart [ J ]. J Bio Chem, 2008, 283 (29) : 20 045-052.
  • 5Catalucei D, Latronico MV, Condorelli G. MicroRNAs control gene expression: importance for cardiac development and pathophysiology [ J ]. Ann N Y Acad Sci, 2008, 1123 (2): 20-29.
  • 6Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP7C and easpase-9 in cardiomyocytes [ J ]. J Cell Sci, 2007, 120 (17) : 3 0454352.
  • 7Kwon C, Han Z, Olson EN., et al. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling [ J ]. PNAS, 2005, 102 (52) : 18 986-991.
  • 8Chen J, Mandel EM, Thomson JM, et al. The role of microRNA-1 and mieroRNA-133 in skeletal muscle proliferation and differentiation [ J ]. Nat C, enet, 2006, 38 (2) : 228-233.
  • 9Care A, Catalueci D, Felicetti F, et al. MieroRNA-133 controls cardiac hypertrophy [J]. Nat Med, 2007, 13 (5): 613-618.
  • 10Xiao J, Luo X, Lin H, et al. MicmRNA miR-133 represses HERG K^ + channel expression contributing to QT prolongation in diabetic berets [ J ]. J Bio Chem, 2007, 282 (17) : 12 363-367.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部